BMJ  2007;334:961-962 (12 May), doi:10.1136/bmj.39204.473252.80

Editorials

Aspirin and cognitive function

Benefit has not yet been shown, but may be due to difficulties in selecting the right outcome measure

The first 150 words of the full text of this article appear below.

Growing old is associated with a greater risk of falls, reduced bone volume, vascular events, cognitive decline, and depression. Although it is relatively straightforward to study the effects of interventions on the physical risks associated with ageing, studying effects on cognitive function is more difficult. Age related cognitive impairment affects about 5% of people over 65 in the developed world, and about half of those affected have memory loss.¹ In this week's BMJ, Kang and colleagues assess the impact of aspirin on cognitive function in a subgroup of elderly women enrolled in the women's health study²—a randomised controlled trial of the effect of aspirin on cardiovascular morbidity and cancer.

What is the evidence on interventions for delaying or preventing age related cognitive decline? Drugs for dementia produce transient symptomatic improvements by enhancing cholinergic neurotransmission but they do not delay progress to severe dementia. Molecular neurobiological and epidemiological . . . [Full text of this article]

Department of Old Age Psychiatry, Royal Cornhill Hospital, Aberdeen, Grampian AB25 2ZH

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Low dose aspirin and cognitive function in the women's health study cognitive cohort

Jae Hee Kang, Nancy Cook, JoAnn Manson, Julie E Buring, and Francine Grodstein
BMJ 2007 334: 987. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Beneficial cognitive effects of treating hypertension are not clear

David Craig, et al.
bmj.com, 3 Jun 2007 [Full text]